A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and Mycoplasma hyopneumoniae combined vaccine
Abstract Background Respiratory diseases impair the health and welfare of growing pigs and impacts farmers’ gains worldwide. Their control through a preventative medical approach has to be tailored according to the pathogens identified at farm level. In the Netherlands, several studies have emphasized the prominent role of Mycoplasma hyopneumoniae, Porcine Circovirus type 2 and Porcine Reproductive and Respiratory Syndrome Virus in such respiratory conditions. Further to the arrival on the Dutch market of the first commercially available bivalent vaccine against PCV2 and M. hyopneumoniae, Porc... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2017 |
Reihe/Periodikum: | Porcine Health Management, Vol 3, Iss 1, Pp 1-7 (2017) |
Verlag/Hrsg.: |
BMC
|
Schlagwörter: | PCV2 / Mycoplasma hyopneumoniae / Bivalent vaccine / Randomised controlled field trial / Animal culture / SF1-1100 / Veterinary medicine / SF600-1100 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26799794 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.1186/s40813-017-0070-5 |